Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. How common it is

Topic: Risk, prevention and care in population studies

It remains unclear whether the combined conditions confer an excess risk of hypoglycaemia-related hospitalisation beyond the risks associated with either condition alone. AimTo determine whether comorbid T2DM and dementia are associated with excess hypoglycaemia-related hospitalisation. Secondary aims were to characterise overall hospital admissions, falls-related admissions, hyperglycaemia-related admissions and mortality across disease states. Hypoglycaemia-related hospitalisation occurred in 6.61% of participants while living with both conditions, compared with 1.88% with T2DM only, 0.91% with dementia only and 0.15% with neither condition. Comorbidity was also associated with the highest overall admission, falls and mortality burden, but these outcomes did not show clear positive additive interactions. The combined hazard substantially exceeded that expected from adding the separate relative hazards associated with each condition. These findings support prioritising safer, cognitively appropriate glycaemic management in this high-risk population.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Donat Ergin, B., Au-Yeung, B., Mattishent, K., Khondoker, M., Minihane, A. M., Holt, R. I., et al. (2026). Excess hypoglycaemia-related hospitalisation in older adults with comorbid type 2 diabetes and dementia: a UK Biobank cohort study. medRxiv (preprint). https://doi.org/10.64898/2026.09.15.26363121

Vancouver

Donat Ergin B, Au-Yeung B, Mattishent K, Khondoker M, Minihane AM, Holt RI, et al. Excess hypoglycaemia-related hospitalisation in older adults with comorbid type 2 diabetes and dementia: a UK Biobank cohort study. medRxiv (preprint). 2026. doi:10.64898/2026.09.15.26363121.

BibTeX

@article{donatergin2026-362b8dca,
  author  = {Donat Ergin, B. and Au-Yeung, B. and Mattishent, K. and Khondoker, M. and Minihane, A. M. and Holt, R. I. and Amin, J. and Dhatariya and others},
  title   = {{Excess hypoglycaemia-related hospitalisation in older adults with comorbid type 2 diabetes and dementia: a UK Biobank cohort study}},
  journal = {medRxiv (preprint)},
  year    = {2026},
  doi     = {10.64898/2026.09.15.26363121},
  url     = {https://doi.org/10.64898/2026.09.15.26363121}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that people with both type 2 diabetes and dementia were hospitalized for low blood sugar far more often than those with either condition alone. It suggests that safer blood sugar management is needed for this group, but it does not test any treatment for Alzheimer's disease itself.

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 4 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 3 of 4; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 38 of the 94 points it could be judged on, which is 40 of 100. Raw total 40 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 40 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 40 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for randomised / blinded because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 38 of the 94 points we could judge it on, which is 40 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (medRxiv (preprint))
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 4 / 4 329,566 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Michael Hornberger: h-index 67 (OpenAlex, whole career)
Institution's track record 1 / 3 University of Southampton: institution h-index 938 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 38 / 94 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 38 of the 94 points we could judge it on is 40 out of 100.
Total 40 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in How common it is

Also tagged “incidence”

1,084 studies in the library carry the topic tag “incidence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Similar studies

More on How common it is

See all studies in How common it is →